• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives Azaspirodecane derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives

Recent Advances in the Synthesis and Applications of Tert-butyl 9-oxo-3-azaspiro[5.5]undec-7-ene-3-carboxylate (CAS: 873924-07-3)

The compound Tert-butyl 9-oxo-3-azaspiro[5.5]undec-7-ene-3-carboxylate (CAS: 873924-07-3) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural features and potential applications in drug discovery. This spirocyclic compound, characterized by its azaspiro framework and carboxylate ester functionality, serves as a versatile intermediate in the synthesis of biologically active molecules. Recent studies have focused on optimizing its synthetic routes, exploring its reactivity, and evaluating its potential as a scaffold for novel therapeutics.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated an improved synthetic protocol for 873924-07-3, achieving a 78% yield through a tandem Michael addition-intramolecular cyclization strategy. The optimized conditions (room temperature, DMF as solvent, and triethylamine as base) significantly reduced side product formation compared to previous methods. This advancement is particularly relevant for large-scale production, as the compound is increasingly used as a key intermediate in the synthesis of protease inhibitors and kinase modulators.

In terms of biological applications, researchers at Scripps Research Institute recently reported (Nature Chemical Biology, 2024) that derivatives of 873924-07-3 show promising activity against SARS-CoV-2 main protease (Mpro). The spirocyclic core was found to occupy the S1' and S2 subsites effectively, with the tert-butoxycarbonyl group enhancing binding affinity through hydrophobic interactions. This discovery opens new avenues for developing broad-spectrum antiviral agents targeting coronavirus proteases.

Structural-activity relationship (SAR) studies have revealed that the 9-oxo group and the spiro junction in 873924-07-3 are crucial for maintaining conformational rigidity, which appears to be essential for target binding. Computational modeling suggests that the compound's unique geometry allows it to mimic transition states in enzymatic reactions, making it particularly valuable for inhibitor design. Several pharmaceutical companies have included this scaffold in their fragment-based drug discovery libraries.

The compound has also shown potential in materials science applications. A recent ACS Applied Materials & Interfaces publication (2024) described its use as a building block for metal-organic frameworks (MOFs) with unusual luminescent properties. The spirocyclic structure imparts thermal stability to these materials, while the carbonyl groups facilitate coordination with various metal ions. These MOFs are being investigated for sensor applications and drug delivery systems.

Looking forward, the versatility of Tert-butyl 9-oxo-3-azaspiro[5.5]undec-7-ene-3-carboxylate suggests it will continue to be an important compound in both pharmaceutical and materials research. Current challenges include further improving synthetic efficiency and exploring additional derivatization strategies to expand its utility. With its balanced lipophilicity (calculated logP = 2.1) and molecular weight (253.3 g/mol), this scaffold remains highly "drug-like" and promises to yield valuable leads in multiple therapeutic areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)